Skip to content
WeighLab

Goldspan Health vs Wisp

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Goldspan Health

Provider comparison

Shoppers who want a sublingual route priced openly beside the injection and who will count 13 charges a year rather than 12.

Semaglutide / month
$229 every 28 daysMonth-to-month (13 charges a year, not 12)
Tirzepatide / month
$299 every 28 daysMonth-to-month (13 charges a year, not 12)
Index 71/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Goldspan Health has the higher Cost-Efficiency Index: 71/100 versus 70/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Goldspan Health
All 50 states
Wisp
39 states + DC for brand-name care; 26 states + DC for sublingual semaglutide

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Goldspan Health

Wisp

Semaglutide / month
Goldspan Health: $229 every 28 daysMonth-to-month (13 charges a year, not 12)
Wisp: $225/moCompounded oral
Tirzepatide / month
Goldspan Health: $299 every 28 daysMonth-to-month (13 charges a year, not 12)
Wisp: Not disclosed
Semaglutide / year (modeled)
Goldspan Health: $2,97713 charges
Wisp: $2,700
Tirzepatide / year (modeled)
Goldspan Health: $3,88713 charges
Wisp: —
State availability
Goldspan Health: All 50 states
Wisp: 39 states + DC for brand-name care; 26 states + DC for sublingual semaglutide
Oral / sublingual option listed
Goldspan Health: Yes
Wisp: Yes
Brand-name access listed
Goldspan Health: Not confirmed
Wisp: Yes
Provider facts checked
Goldspan Health: October 2026
Wisp: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Goldspan Health

Shoppers who want a sublingual route priced openly beside the injection and who will count 13 charges a year rather than 12.

Reasons to consider it

  • Prices ten GLP-1 products openly before any account — standard injections with a B12 or glycine base, plus low-dose injections and daily sublingual microdoses
  • Each plan card itemizes what the figure buys: the clinician evaluation, the medication, injection supplies, two-day shipping and clinical-team access
  • States the billing cycle honestly on the plan card and the order timeline as 28 days and four weeks

What to weigh up

  • The hero prints "/month" over a plan billed every 28 days, which is 13 charges a year rather than 12
  • "Pause, delay, or cancel at any time" sits against a refund policy saying all sales are final once an order is placed, with a full refund only if the clinician declines to prescribe
  • The tirzepatide low-dose sublingual page lists "Compounded sublingual semaglutide microdose" among what the price includes — the wrong molecule on a product page

Wisp

Shoppers who want brand-name injectables with a sublingual semaglutide option.

Reasons to consider it

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

What to weigh up

  • The $99 Weight Care Consult is a care charge, not a Zepbound price; no monthly billing period is stated, and the medication is paid for separately at your pharmacy
  • The compounded semaglutide is sublingual drops; Wisp says this formulation has not been tested in the human body, so effectiveness in patients may vary
  • Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Goldspan HealthWisp
Normalized Cost/Month
Goldspan Health:
56/100
Wisp:
58/100
Price Transparency
Goldspan Health:
86/100
Wisp:
86/100
Nationwide Access
Goldspan Health:
86/100
Wisp:
66/100
Formulation Options
Goldspan Health:
77/100
Wisp:
77/100
Clinical Oversight
Goldspan Health:
68/100
Wisp:
82/100
Contract Flexibility
Goldspan Health:
45/100
Wisp:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.